期刊文献+

儿童川崎病并发EB病毒感染NF-κB信号通路表达及其影响 被引量:6

Expression of NF-κB signaling pathway in children with Kawasaki disease EB virus infection and its effect
原文传递
导出
摘要 目的 探究儿童川崎病(KD)并发EB病毒(EBV)感染核因子κB(NF-κB)信号通路表达及其对细胞炎症因子释放和冠脉损伤(CAL)的影响。方法 选取2017年12月—2020年12月抚州市第一人民医院儿科收治的KD患儿89例,根据EBV DNA检测结果分为EBV感染组30例和无EBV感染组59例,采用酶联免疫吸附法检测患儿血清炎症因子[白细胞介素(IL)-6、IL-8、IL-10、IL-1β、肿瘤坏死因子α(TNF-α)]、基质金属蛋白酶(MMP)-2、MMP-9及其特异性组织抑制剂1(TIMP-1)、NF-κB及其抑制蛋白(IκBα)表达,实时荧光定量聚合酶链式反应法(PCR)检测NF-κB、IκB mRNA水平,统计两组患儿CAL发生率。结果 EBV感染组患儿外周血白细胞计数、血清IL-6、IL-8、IL-10、IL-1β、TNF-α、MMP-2、MMP-9、NF-κB及其mRNA水平高于无EBV感染组,TIMP-1、IκBα及其mRNA水平均低于无EBV感染组(P<0.05);EBV感染组CAL发生率为43.33%(13/30),高于无EBV感染组(P<0.05)。结论 合并EBV感染的川崎病患儿外周血炎症细胞因子水平上调,CAL发生率明显升高,EBV感染可能通过激活NF-κB信号通路介导炎症反应造成CAL。 OBJECTIVE To investigate the expression of nuclear factor-κB(NF-κB) signaling pathway in children with Kawasaki disease(KD) epstein-Barr virus(EBV) infection and its effect on the release of inflammatory cytokines and coronary artery lesion(CAL). METHODS A total of 89 children with KD admitted to Pediatrics Department of Fuzhou First People′s Hospital from Dec 2017 to Dec 2020 were selected and divided into 30 cases of EBV infection group and 59 cases of non-EBV infection group according to the results of EBV DNA testing. The expression levels of serum inflammatory factors [interleukin(IL-6, IL-8, IL-10, IL-1β), tumor necrosis factor α(TNF-α)], matrix metalloproteinase(MMP-2, MMP-9) and its tissue inhibitor of metalloproteinase-1(TIMP-1), NF-κB and its profilin(IκBα) were detected by enzyme-linked immunosorbent assay(ELISA). The levels of NF-κB and IκB mRNA were detected by real-time fluorescent quantitative polymerase chain reaction(PCR). The incidence of CAL in both groups was calculated. RESULTS The levels of peripheral blood white blood cell count, serum IL-6, IL-8, IL-10, IL-1β, TNF-α, MMP-2, MMP-9, NF-κB and its mRNA in the EBV infection group were significantly higher than those in non-EBV infection group, while levels of TIMP-1, IκBα and its mRNA were significantly lower than those in non-EBV infection group(P<0.05). The incidence of CAL in EBV infection group was 43.33%(13/30), significantly higher than that in non-EBV infection group(P<0.05). CONCLUSION The levels of inflammatory cytokines in peripheral blood of children with KD combined with EBV infection were up-regulated, and incidence of CAL was significantly increased. EBV infection may mediate inflammation response by activating NF-κB signaling pathway and cause CAL.
作者 陈丽 李燕燕 姜婷 邓群繁 邓晓敏 CHEN Li;LI Yan-yan;JIANG Ting;DENG Qun-fan;DENG Xiao-min(Fuzhou Medical College of Nanchang University,Fuzhou,Jiangxi 344000,China;不详)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2022年第3期476-480,共5页 Chinese Journal of Nosocomiology
基金 江苏省高等学校重点科研基金资助项目(19A320042)。
关键词 川崎病 EB病毒 冠脉损伤 炎症细胞因子 核因子-ΚB信号通路 Kawasaki disease Epstein-Barr virus Coronary artery lesion Inflammatory cytokine Nuclear factor-κB signaling pathway
  • 相关文献

参考文献1

二级参考文献22

  • 1Duan C, Du ZD, Wang Y, et al. Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease. World J Pediatr, 2014,10(3):232-237.
  • 2Makino N, Nakamura Y, Yashiro M, et al. Descriptive epidemiology of Kawasaki disease in Japan,2011-2012: from the results of the 22nd nationwide survey. J Epidemiol, 2015, 25(3): 239-245.
  • 3Kim GB, Park S, Kwon BS, et al. Evaluation of the temporal association between Kawasaki disease and viral infections in South Korea. Korean Circ J, 2014,44(4): 250-254.
  • 4Tsai HC, Chang LY, Lu CY, et al. Transmission of acute infectious illness among cases of Kawasaki disease and their household members. J Formos Med Assoc, 2015, 114(1):72-76.
  • 5Bajolle F, Meritet JF, Rozenberg F, et al. Markers of a recent bocavirus infection in children with Kawasaki disease: a year prospective study. Pathol Biol {Paris), 2014, 62(6); 365-368.
  • 6Tremoulet AH, Jain S, Jaggi P, et al. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet,2014, 383(9930):1731-1738.
  • 7JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J, 2014,78(10):2521-2562.
  • 8de Zorzi A, Colan SD, Gauvreau K, et al. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr, 1998, 133(2):254-258.
  • 9Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation, 2004,110(17): 2747-2771.
  • 10Principi N, Rigante D, Esposito S. The role of infection in Kawasaki syndrome. J Infect, 2013,67( 1) : 1-10.

共引文献23

同被引文献77

引证文献6

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部